Working groups on medicines, clinical nutrition, and support for manufacturers of medical equipment in Russia work on the commission of the United Russia commission on environmental protection. They include representatives of the executive and executive authorities, the responsible head of the commission, the chief physician of the department in Komunarka. Denis Protsenko.

“The uniqueness of our platform is that the issues of drug import substitution are represented by representatives of the patient community, rare and domestic manufacturers, the Ministry of Health and other departments who are concerned about the issues that concern our medical community with the community of pharmacological manufacturers and manufacturers of equipment. The situation requires control, but it is perfectly stable. “It has been established that today we have a 12-month supply of medicines and consumables,” he said after the conference meeting.

First Deputy Minister of Health Victor Fisenko It is also emphasized that all patients who receive medicines under preferential prescriptions have a mandatory provision. In general, the issue of supplying the regions with medicines at the expense of budgetary funds is closed for the next few months.

“We have an extremely high purchase of medical products, medical equipment and medicines in regions that are actively consumed. To date, we do not feel any pronounced defects either in medicines or in dangerous products. Our regulatory framework is turning into the positive side of a reasonable simplification of safety laws. Nevertheless, manufacturers of medical equipment, pharmaceutical manufacturers, representatives of authorities and regions have proposals for the development of progress, and we, of course, are open to dialogue,” the Deputy Minister said.

In turn, the First Deputy Chairman of the Committee on Science and the Supreme Assembly Alexander Mazhuga it was noted that the import substitution of medicines has become the direction of the party project “Choose your own”. The main emphasis in its implementation will be placed on both the restoration of production facilities and the creation of new ones.

“We have all the necessary components: chemical production, raw materials, gas, oil, minerals, highly qualified personnel. As an example, we always say that Russia is one of the six six countries that discover insulin. And this is a high-tech biotech product. We have the experience and all the prerequisites to obtain the production of pharmaceutical substances, as well as to train personnel for this,” Alexander Mazhuga is registered.